Dynavax Technologies Corporation (DVAX) Social Stream



Dynavax Technologies Corporation (DVAX): $11.88

0.42 (+3.66%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add DVAX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#31 of 360

in industry

DYNAVAX TECHNOLOGIES CORP (DVAX) Price Targets From Analysts

Use the tables below to see what analysts covering DYNAVAX TECHNOLOGIES CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 3 $30 $23 $26.5 $14.03 88.88%
2022-05-09 3 $30 $28 $29 $14.03 106.7%
2022-08-08 5 $38 $28 $32 $14.03 128.08%
2022-10-20 5 $38 $22 $29.5 $14.03 110.26%
2022-11-04 5 $30 $21 $25.25 $14.03 79.97%
2023-01-10 5 $28 $21 $24 $14.03 71.06%
2023-08-04 5 $27 $21 $24.25 $14.03 72.84%
2023-08-07 5 $27 $21 $24.5 $14.03 74.63%
2023-09-18 4 $27 $25 $25.666 $14.03 82.94%
2023-11-06 4 $28 $25 $26 $14.03 85.32%

The Trend in the Analyst Price Target


Over the past 18 months, DVAX's average price target has gone down $3.

Over the past 43 weeks, DVAX's average upside potential has been 98.71%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-03 5 27 21 24.500 11.02 122.32%
2023-08-04 5 27 21 24.500 14.50 68.97%
2023-08-04 5 27 21 24.250 14.50 67.24%
2023-09-18 4 27 25 25.666 13.57 89.14%
2023-11-06 4 28 25 26.000 13.51 92.45%

DVAX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 22 months, DVAX's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, DYNAVAX TECHNOLOGIES CORP's number of analysts covering the stock is greater than 190.64% of them.
  • DYNAVAX TECHNOLOGIES CORP's variance in analysts' estimates is lower than -65.95% of Pharmaceutical Products stocks.
  • DYNAVAX TECHNOLOGIES CORP's upside potential (average analyst target price relative to current price) is greater than 941.47% of stocks in the mid market cap category.
  • DYNAVAX TECHNOLOGIES CORP's average analyst price target is higher than 467.47% of stocks in the mid market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to DYNAVAX TECHNOLOGIES CORP are TGTX, OPK, and MNKD.

Make investment decisions regarding DVAX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!